Amyloid Beta-directed Antibodies
- Name
- Amyloid Beta-directed Antibodies
- Accession Number
- DBCAT005532
- Description
-
Monoclonal antibodies directed towards amyloid beta plaques.
- Drugs
-
Drug Drug Description Aducanumab A monoclonal antibody indicated in the treatment of Alzheimer's disease. - Drugs & Drug Targets
-
Drug Target Type Aducanumab Amyloid beta A4 protein target